Published in Cancer Lett on July 25, 2012
Microenvironmental regulation of therapeutic response in cancer. Trends Cell Biol (2014) 1.57
Gastric cancer stem cells: a novel therapeutic target. Cancer Lett (2013) 1.04
CD271 defines a stem cell-like population in hypopharyngeal cancer. PLoS One (2013) 1.00
Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma. Clin Exp Metastasis (2014) 0.86
Endothelial cells promote stem-like phenotype of glioma cells through activating the Hedgehog pathway. J Pathol (2014) 0.83
Hypoxia in head and neck squamous cell carcinoma. ISRN Otolaryngol (2012) 0.82
Therapeutic inhibition of the MDM2-p53 interaction prevents recurrence of adenoid cystic carcinomas. Clin Cancer Res (2016) 0.80
NOTCH1 inhibition enhances the efficacy of conventional chemotherapeutic agents by targeting head neck cancer stem cell. Sci Rep (2016) 0.80
Interaction between gastric cancer stem cells and the tumor microenvironment. J Gastroenterol (2014) 0.78
Targeting Head and Neck Cancer Stem Cells: Current Advances and Future Challenges. J Dent Res (2015) 0.75
Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin. Mol Cancer (2017) 0.75
Cancer Stem Cells in Moderately Differentiated Buccal Mucosal Squamous Cell Carcinoma Express Components of the Renin-Angiotensin System. Front Surg (2016) 0.75
Cancer Stem Cells in Moderately Differentiated Lip Squamous Cell Carcinoma Express Components of the Renin-Angiotensin System. Front Surg (2017) 0.75
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A (2003) 59.17
Stem cells, cancer, and cancer stem cells. Nature (2001) 50.27
The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell (2008) 46.08
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med (1997) 32.63
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature (2006) 27.91
Identification of a cancer stem cell in human brain tumors. Cancer Res (2003) 24.02
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell (2007) 22.89
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature (1994) 21.59
Identification of pancreatic cancer stem cells. Cancer Res (2007) 18.36
Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med (1996) 17.51
Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res (2006) 17.42
Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell (2009) 16.06
Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer (2008) 15.20
Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res (2005) 13.89
Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A (2007) 13.58
Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A (2007) 11.94
A perivascular niche for brain tumor stem cells. Cancer Cell (2007) 11.55
Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature (2003) 11.23
Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell (2008) 9.92
WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci U S A (2007) 4.97
IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J Clin Invest (2007) 4.71
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J Clin Invest (2010) 4.22
Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell (2010) 3.70
Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res (2008) 3.32
Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia. Proc Natl Acad Sci U S A (2012) 3.21
Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck (2010) 2.76
Engineering and characterization of functional human microvessels in immunodeficient mice. Lab Invest (2001) 2.61
The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Rev (2011) 2.56
Tumor-initiating cells are rare in many human tumors. Cell Stem Cell (2010) 2.54
Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors. Cancer Res (2007) 2.35
Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev (2007) 2.31
Cancer stem cell niche: the place to be. Cancer Res (2011) 2.14
Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells. Cancer Res (2010) 1.88
Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma. PLoS One (2011) 1.87
CD133+ glioblastoma stem-like cells are radiosensitive with a defective DNA damage response compared with established cell lines. Clin Cancer Res (2009) 1.72
A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy. Cancer Lett (2009) 1.49
Evidence for label-retaining tumour-initiating cells in human glioblastoma. Brain (2011) 1.48
UM-SCC-104: a new human papillomavirus-16-positive cancer stem cell-containing head and neck squamous cell carcinoma cell line. Head Neck (2011) 1.45
Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance. Am J Pathol (2011) 1.44
Cross talk initiated by endothelial cells enhances migration and inhibits anoikis of squamous cell carcinoma cells through STAT3/Akt/ERK signaling. Neoplasia (2009) 1.42
Frequency of cells expressing CD44, a head and neck cancer stem cell marker: correlation with tumor aggressiveness. Head Neck (2011) 1.35
ERK1/2 regulation of CD44 modulates oral cancer aggressiveness. Cancer Res (2011) 1.34
Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients. Int J Cancer (2010) 1.31
Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes. Cancer Lett (2009) 1.27
Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity. Neuro Oncol (2010) 1.15
Precancerous stem cells can serve as tumor vasculogenic progenitors. PLoS One (2008) 1.14
Isolation and characterization of cancer stem-like side population cells in human oral cancer cells. Oral Oncol (2011) 1.10
Enhancive effects of Lewis y antigen on CD44-mediated adhesion and spreading of human ovarian cancer cell line RMG-I. J Exp Clin Cancer Res (2011) 1.08
In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line. Head Neck (2009) 1.06
Resistance to apoptosis-inducing stimuli in CD44+ head and neck squamous cell carcinoma cells. Head Neck (2011) 0.94
CD44: a cancer stem cell-related biomarker with predictive potential for radiotherapy. Clin Cancer Res (2010) 0.93
Endothelial derived factors inhibit anoikis of head and neck cancer stem cells. Oral Oncol (2011) 0.87
CD44 as a stem cell marker in head and neck squamous cell carcinoma. Oncol Rep (2011) 0.86
Dental pulp tissue engineering with stem cells from exfoliated deciduous teeth. J Endod (2008) 2.19
Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells. Cancer Res (2010) 1.88
Multiple roles for the receptor tyrosine kinase axl in tumor formation. Cancer Res (2005) 1.87
Specific occlusion of murine and human tumor vasculature by VCAM-1-targeted recombinant fusion proteins. J Natl Cancer Inst (2005) 1.66
Bcl-2 orchestrates a cross-talk between endothelial and tumor cells that promotes tumor growth. Cancer Res (2007) 1.53
Cross talk initiated by endothelial cells enhances migration and inhibits anoikis of squamous cell carcinoma cells through STAT3/Akt/ERK signaling. Neoplasia (2009) 1.42
Bcl-2 acts in a proangiogenic signaling pathway through nuclear factor-kappaB and CXC chemokines. Cancer Res (2005) 1.32
Antiangiogenic effect of TW37, a small-molecule inhibitor of Bcl-2. Cancer Res (2006) 1.27
The biology of head and neck cancer stem cells. Oral Oncol (2011) 1.25
Endothelial cells enhance tumor cell invasion through a crosstalk mediated by CXC chemokine signaling. Neoplasia (2008) 1.21
Expanding circle of inhibition: small-molecule inhibitors of Bcl-2 as anticancer cell and antiangiogenic agents. J Clin Oncol (2008) 1.13
The unfolded protein response induces the angiogenic switch in human tumor cells through the PERK/ATF4 pathway. Cancer Res (2012) 1.12
Effect of ProRoot MTA on pulp cell apoptosis and proliferation in vitro. J Endod (2005) 1.05
Tooth slice-based models for the study of human dental pulp angiogenesis. J Endod (2007) 1.01
Modeling the VEGF-Bcl-2-CXCL8 pathway in intratumoral agiogenesis. Bull Math Biol (2007) 1.00
Orosphere assay: a method for propagation of head and neck cancer stem cells. Head Neck (2012) 0.99
Level of endothelial cell apoptosis required for a significant decrease in microvessel density. Exp Cell Res (2007) 0.98
Hypoxia enhances the angiogenic potential of human dental pulp cells. J Endod (2010) 0.96
TW-37, a small-molecule inhibitor of Bcl-2, mediates S-phase cell cycle arrest and suppresses head and neck tumor angiogenesis. Mol Cancer Ther (2009) 0.96
A hydrogel scaffold that maintains viability and supports differentiation of dental pulp stem cells. Dent Mater (2012) 0.96
The effect of novel fluorapatite surfaces on osteoblast-like cell adhesion, growth, and mineralization. Tissue Eng Part A (2010) 0.95
Efficient in vivo vascularization of tissue-engineering scaffolds. J Tissue Eng Regen Med (2010) 0.94
Endothelial interleukin-6 defines the tumorigenic potential of primary human cancer stem cells. Stem Cells (2014) 0.93
Effects of morphogen and scaffold porogen on the differentiation of dental pulp stem cells. J Endod (2010) 0.93
From combinatorial peptide selection to drug prototype (I): targeting the vascular endothelial growth factor receptor pathway. Proc Natl Acad Sci U S A (2010) 0.92
Salivary gland cancer stem cells. Oral Oncol (2013) 0.92
Inhibition of histone deacetylase impacts cancer stem cells and induces epithelial-mesenchyme transition of head and neck cancer. PLoS One (2013) 0.92
Dental pulp stem cells in regenerative dentistry. Odontology (2011) 0.91
TLR4 mediates LPS-induced VEGF expression in odontoblasts. J Endod (2006) 0.91
Transcriptional targeting of tumor endothelial cells for gene therapy. Adv Drug Deliv Rev (2009) 0.91
Angiogenic activity of dentin matrix components. J Endod (2010) 0.90
Indirect pulp capping in the primary dentition: a 4 year follow-up study. J Clin Pediatr Dent (2006) 0.90
Amino acid deprivation promotes tumor angiogenesis through the GCN2/ATF4 pathway. Neoplasia (2013) 0.90
Metronomic small molecule inhibitor of Bcl-2 (TW-37) is antiangiogenic and potentiates the antitumor effect of ionizing radiation. Int J Radiat Oncol Biol Phys (2010) 0.88
The response of VEGF-stimulated endothelial cells to angiostatic molecules is substrate-dependent. BMC Cell Biol (2005) 0.88
Indirect pulp treatment: in vivo outcomes of an adhesive resin system vs calcium hydroxide for protection of the dentin-pulp complex. Pediatr Dent (2002) 0.88
Metronomic dosing of BH3 mimetic small molecule yields robust antiangiogenic and antitumor effects. Cancer Res (2011) 0.87
Endothelial derived factors inhibit anoikis of head and neck cancer stem cells. Oral Oncol (2011) 0.87
Characterization of tumorigenic cell lines from the recurrence and lymph node metastasis of a human salivary mucoepidermoid carcinoma. Oral Oncol (2013) 0.87
Adhesive resin and the hydrophilic monomer HEMA induce VEGF expression on dental pulp cells and macrophages. Dent Mater (2005) 0.86
Inhibition of Vascular Endothelial Growth Factor Receptor-1/Wnt/{beta}-catenin Crosstalk Leads to Tumor Cell Death. Clin Cancer Res (2009) 0.86
The stimulation of adipose-derived stem cell differentiation and mineralization by ordered rod-like fluorapatite coatings. Biomaterials (2012) 0.85
Regenerative endodontics in light of the stem cell paradigm. Int Dent J (2011) 0.84
Combined effects of simvastatin and enamel matrix derivative on odontoblastic differentiation of human dental pulp cells. J Endod (2012) 0.84
Spatial distribution of cancer stem cells in head and neck squamous cell carcinomas. J Oral Pathol Med (2014) 0.82
Telomeres and tissue engineering: the potential roles of TERT in VEGF-mediated angiogenesis. Stem Cell Rev (2012) 0.81
Quantification of human angiogenesis in immunodeficient mice using a photon counting-based method. Biotechniques (2007) 0.81
In vitro differentiation and mineralization of dental pulp stem cells on enamel-like fluorapatite surfaces. Tissue Eng Part C Methods (2012) 0.81
Small-molecule inhibitors reveal a new function for Bcl-2 as a proangiogenic signaling molecule. Curr Top Microbiol Immunol (2011) 0.81
Endothelial cell Bcl-2 and lymph node metastasis in patients with oral squamous cell carcinoma. J Oral Pathol Med (2011) 0.80
RAIN-Droplet: a novel 3D in vitro angiogenesis model. Lab Invest (2012) 0.80
Growth of human blood vessels in severe combined immunodeficient mice. A new in vivo model system of angiogenesis. Methods Mol Med (2003) 0.79
Synergistic combination of small molecule inhibitor and RNA interference against antiapoptotic Bcl-2 protein in head and neck cancer cells. Mol Pharm (2013) 0.79
Effect of adhesive restorations over incomplete dentin caries removal: 5-year follow-up study in primary teeth. J Dent Child (Chic) (2009) 0.78
Fluorapatite enhances mineralization of mesenchymal/endothelial cocultures. Tissue Eng Part A (2013) 0.78
Effect of lipopolysaccharides on vascular endothelial growth factor expression in mouse pulp cells and macrophages. Eur J Oral Sci (2003) 0.78
Gene expression analysis of resident macrophages in lipopolysaccharide-stimulated rat molar pulps. J Endod (2011) 0.78
Vascular endothelial growth factor receptor-2 expression in the pulp of human primary and young permanent teeth. J Endod (2007) 0.78
Gene expression analysis of immunostained endothelial cells isolated from formaldehyde-fixated paraffin embedded tumors using laser capture microdissection--a technical report. Microsc Res Tech (2009) 0.77
The effectiveness of propolis on gingivitis: a randomized controlled trial. J Altern Complement Med (2014) 0.76
TGF-β1 regulates the invasive and metastatic potential of mucoepidermoid carcinoma cells. J Oral Pathol Med (2011) 0.76
Laser-capture microdissection for Factor VIII-expressing endothelial cells in cancer tissues. Methods Mol Biol (2011) 0.76
Expression of angiogenic factors in rat periapical lesions. J Endod (2011) 0.76
Laser capture microdissection in dentistry. Int J Dent (2011) 0.75
Ketoprofen inhibits expression of inflammatory mediators in human dental pulp cells. J Endod (2013) 0.75